世界の腎疾患市場：市場規模・現状・予測

• 英文タイトル：Global Renal Disease Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7950 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、腎疾患のグローバル市場について調査・分析したレポートで、種類別（急性腎臓の問題、慢性腎臓病、その他）、用途別（病院、診療所、リサーチセンター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・腎疾患の世界市場規模 ・主要企業別市場シェア ・腎疾患の世界市場規模：種類別（急性腎臓の問題、慢性腎臓病、その他） ・腎疾患の世界市場規模：用途別（病院、診療所、リサーチセンター、その他） ・腎疾患のアメリカ市場規模（種類別、用途別） ・腎疾患のヨーロッパ市場規模（種類別、用途別） ・腎疾患の中国市場規模（種類別、用途別） ・腎疾患の日本市場規模（種類別、用途別） ・腎疾患の東南アジア市場規模（種類別、用途別） ・腎疾患のインド市場規模（種類別、用途別） ・腎疾患の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・腎疾患の世界市場予測（2019年-2025年） ・腎疾患の地域別市場予測（2019年-2025年） ...

Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases.Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.
In 2018, the global Renal Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Renal Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Renal Disease development in United States, Europe and China.

The key players covered in this study
Abbott (US)
Amgen Inc. (US)
Baxter (US)
Bristol-Myers Squibb Company (US)
Keryx Biopharmaceuticals, Inc. (US)
NephroGenex, Inc. (US)
Novartis AG (Switzerland)
Pfizer Inc.(US)
Sanofi (France)
Shire Pharmaceuticals Limited (Republic of Ireland)

Market segment by Type, the product can be split into
Acute Kidney Problems
Chronic Kidney Diseases
Others

Market segment by Application, split into
Hospital
Clinic
Research Center
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Renal Disease status, future forecast, growth opportunity, key market and key players.
To present the Renal Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Renal Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Renal Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Acute Kidney Problems
1.4.3 Chronic Kidney Diseases
1.4.4 Others
1.5 Market by Application
1.5.1 Global Renal Disease Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Center
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Renal Disease Market Size
2.2 Renal Disease Growth Trends by Regions
2.2.1 Renal Disease Market Size by Regions (2014-2025)
2.2.2 Renal Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Renal Disease Market Size by Manufacturers
3.1.1 Global Renal Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Renal Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Renal Disease Market Concentration Ratio (CR5 and HHI)
3.2 Renal Disease Key Players Head office and Area Served
3.3 Key Players Renal Disease Product/Solution/Service
3.4 Date of Enter into Renal Disease Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Renal Disease Market Size by Type (2014-2019)
4.2 Global Renal Disease Market Size by Application (2014-2019)

5 United States
5.1 United States Renal Disease Market Size (2014-2019)
5.2 Renal Disease Key Players in United States
5.3 United States Renal Disease Market Size by Type
5.4 United States Renal Disease Market Size by Application

6 Europe
6.1 Europe Renal Disease Market Size (2014-2019)
6.2 Renal Disease Key Players in Europe
6.3 Europe Renal Disease Market Size by Type
6.4 Europe Renal Disease Market Size by Application

7 China
7.1 China Renal Disease Market Size (2014-2019)
7.2 Renal Disease Key Players in China
7.3 China Renal Disease Market Size by Type
7.4 China Renal Disease Market Size by Application

8 Japan
8.1 Japan Renal Disease Market Size (2014-2019)
8.2 Renal Disease Key Players in Japan
8.3 Japan Renal Disease Market Size by Type
8.4 Japan Renal Disease Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Renal Disease Market Size (2014-2019)
9.2 Renal Disease Key Players in Southeast Asia
9.3 Southeast Asia Renal Disease Market Size by Type
9.4 Southeast Asia Renal Disease Market Size by Application

10 India
10.1 India Renal Disease Market Size (2014-2019)
10.2 Renal Disease Key Players in India
10.3 India Renal Disease Market Size by Type
10.4 India Renal Disease Market Size by Application

11 Central & South America
11.1 Central & South America Renal Disease Market Size (2014-2019)
11.2 Renal Disease Key Players in Central & South America
11.3 Central & South America Renal Disease Market Size by Type
11.4 Central & South America Renal Disease Market Size by Application

12 International Players Profiles
12.1 Abbott (US)
12.1.1 Abbott (US) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Renal Disease Introduction
12.1.4 Abbott (US) Revenue in Renal Disease Business (2014-2019)
12.1.5 Abbott (US) Recent Development
12.2 Amgen Inc. (US)
12.2.1 Amgen Inc. (US) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Renal Disease Introduction
12.2.4 Amgen Inc. (US) Revenue in Renal Disease Business (2014-2019)
12.2.5 Amgen Inc. (US) Recent Development
12.3 Baxter (US)
12.3.1 Baxter (US) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Renal Disease Introduction
12.3.4 Baxter (US) Revenue in Renal Disease Business (2014-2019)
12.3.5 Baxter (US) Recent Development
12.4 Bristol-Myers Squibb Company (US)
12.4.1 Bristol-Myers Squibb Company (US) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Renal Disease Introduction
12.4.4 Bristol-Myers Squibb Company (US) Revenue in Renal Disease Business (2014-2019)
12.4.5 Bristol-Myers Squibb Company (US) Recent Development
12.5 Keryx Biopharmaceuticals, Inc. (US)
12.5.1 Keryx Biopharmaceuticals, Inc. (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Renal Disease Introduction
12.5.4 Keryx Biopharmaceuticals, Inc. (US) Revenue in Renal Disease Business (2014-2019)
12.5.5 Keryx Biopharmaceuticals, Inc. (US) Recent Development
12.6 NephroGenex, Inc. (US)
12.6.1 NephroGenex, Inc. (US) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Renal Disease Introduction
12.6.4 NephroGenex, Inc. (US) Revenue in Renal Disease Business (2014-2019)
12.6.5 NephroGenex, Inc. (US) Recent Development
12.7 Novartis AG (Switzerland)
12.7.1 Novartis AG (Switzerland) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Renal Disease Introduction
12.7.4 Novartis AG (Switzerland) Revenue in Renal Disease Business (2014-2019)
12.7.5 Novartis AG (Switzerland) Recent Development
12.8 Pfizer Inc.(US)
12.8.1 Pfizer Inc.(US) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Renal Disease Introduction
12.8.4 Pfizer Inc.(US) Revenue in Renal Disease Business (2014-2019)
12.8.5 Pfizer Inc.(US) Recent Development
12.9 Sanofi (France)
12.9.1 Sanofi (France) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Renal Disease Introduction
12.9.4 Sanofi (France) Revenue in Renal Disease Business (2014-2019)
12.9.5 Sanofi (France) Recent Development
12.10 Shire Pharmaceuticals Limited (Republic of Ireland)
12.10.1 Shire Pharmaceuticals Limited (Republic of Ireland) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Renal Disease Introduction
12.10.4 Shire Pharmaceuticals Limited (Republic of Ireland) Revenue in Renal Disease Business (2014-2019)
12.10.5 Shire Pharmaceuticals Limited (Republic of Ireland) Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Renal Disease Key Market Segments
Table Key Players Renal Disease Covered
Table Global Renal Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Renal Disease Market Size Market Share by Type 2014-2025
Figure Acute Kidney Problems Figures
Table Key Players of Acute Kidney Problems
Figure Chronic Kidney Diseases Figures
Table Key Players of Chronic Kidney Diseases
Figure Others Figures
Table Key Players of Others
Table Global Renal Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Research Center Case Studies
Figure Others Case Studies
Figure Renal Disease Report Years Considered
Table Global Renal Disease Market Size 2014-2025 (Million US$)
Figure Global Renal Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Renal Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Renal Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Renal Disease Market Share by Regions 2014-2019
Figure Global Renal Disease Market Share by Regions 2014-2019
Figure Global Renal Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Renal Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Renal Disease Market Share by Manufacturers (2014-2019)
Figure Global Renal Disease Market Share by Manufacturers in 2018
Table Global Renal Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Renal Disease Product/Solution/Service
Table Date of Enter into Renal Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Renal Disease Market Size by Type (2014-2019) (Million US$)
Table Global Renal Disease Market Size Share by Type (2014-2019)
Figure Global Renal Disease Market Size Market Share by Type (2014-2019)
Table Global Renal Disease Market Size by Application (2014-2019) (Million US$)
Table Global Renal Disease Market Size Share by Application (2014-2019)
Figure Global Renal Disease Market Size Market Share by Application (2014-2019)
Figure Global Renal Disease Revenue Market Share by Application in 2018
Figure United States Renal Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Renal Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Renal Disease Market Share (2018-2019)
Table United States Renal Disease Market Size by Type (2014-2019) (Million US$)
Table United States Renal Disease Market Share by Type (2014-2019)
Table United States Renal Disease Market Size by Application (2014-2019) (Million US$)
Table United States Renal Disease Market Share by Application (2014-2019)
Figure Europe Renal Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Renal Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Renal Disease Market Share (2018-2019)
Table Europe Renal Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Renal Disease Market Share by Type (2014-2019)
Table Europe Renal Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Renal Disease Market Share by Application (2014-2019)
Figure China Renal Disease Market Size 2014-2019 (Million US$)
Table China Key Players Renal Disease Revenue (2018-2019) (Million US$)
Table China Key Players Renal Disease Market Share (2018-2019)
Table China Renal Disease Market Size by Type (2014-20189) (Million US$)
Table China Renal Disease Market Share by Type (2014-2019)
Table China Renal Disease Market Size by Application (2014-2019) (Million US$)
Table China Renal Disease Market Share by Application (2014-2019)
Figure Japan Renal Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Renal Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Renal Disease Market Share (2018-2019)
Table Japan Renal Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Renal Disease Market Share by Type (2014-2019)
Table Japan Renal Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Renal Disease Market Share by Application (2014-2019)
Figure Southeast Asia Renal Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Renal Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Renal Disease Market Share (2018-2019)
Table Southeast Asia Renal Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Renal Disease Market Share by Type (2014-2019)
Table Southeast Asia Renal Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Renal Disease Market Share by Application (2014-2019)
Figure India Renal Disease Market Size 2014-2019 (Million US$)
Table India Key Players Renal Disease Revenue (2018-2019) (Million US$)
Table India Key Players Renal Disease Market Share (2018-2019)
Table India Renal Disease Market Size by Type (2014-2019) (Million US$)
Table India Renal Disease Market Share by Type (2014-2019)
Table India Renal Disease Market Size by Application (2014-2019) (Million US$)
Table India Renal Disease Market Share by Application (2014-2019)
Figure Central & South America Renal Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Renal Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Renal Disease Market Share (2018-2019)
Table Central & South America Renal Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Renal Disease Market Share by Type (2014-2019)
Table Central & South America Renal Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Renal Disease Market Share by Application (2014-2019)
Table Abbott (US) Company Details
Table Abbott (US) Revenue in Renal Disease Business (2014-2019) (Million US$)
Figure Abbott (US) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Abbott (US) Recent Development
Table Amgen Inc. (US) Company Details
Table Amgen Inc. (US) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure Amgen Inc. (US) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Amgen Inc. (US) Recent Development
Table Baxter (US) Company Details
Table Baxter (US) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure Baxter (US) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Baxter (US) Recent Development
Table Bristol-Myers Squibb Company (US) Company Details
Table Bristol-Myers Squibb Company (US) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company (US) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Bristol-Myers Squibb Company (US) Recent Development
Table Keryx Biopharmaceuticals, Inc. (US) Company Details
Table Keryx Biopharmaceuticals, Inc. (US) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure Keryx Biopharmaceuticals, Inc. (US) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Keryx Biopharmaceuticals, Inc. (US) Recent Development
Table NephroGenex, Inc. (US) Company Details
Table NephroGenex, Inc. (US) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure NephroGenex, Inc. (US) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table NephroGenex, Inc. (US) Recent Development
Table Novartis AG (Switzerland) Company Details
Table Novartis AG (Switzerland) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure Novartis AG (Switzerland) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Novartis AG (Switzerland) Recent Development
Table Pfizer Inc.(US) Company Details
Table Pfizer Inc.(US) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure Pfizer Inc.(US) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Pfizer Inc.(US) Recent Development
Table Sanofi (France) Company Details
Table Sanofi (France) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure Sanofi (France) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Sanofi (France) Recent Development
Table Shire Pharmaceuticals Limited (Republic of Ireland) Company Details
Table Shire Pharmaceuticals Limited (Republic of Ireland) Revenue in Renal Disease Business (2014-2019)(Million US$)
Figure Shire Pharmaceuticals Limited (Republic of Ireland) Revenue Growth Rate in Renal Disease Business (2014-2019)
Table Shire Pharmaceuticals Limited (Republic of Ireland) Recent Development
Table Global Renal Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Renal Disease Market Size Share by Regions (2019-2025)
Figure Global Renal Disease Market Size Share by Regions in 2025
Figure United States Renal Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Renal Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Renal Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Renal Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Renal Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Renal Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Renal Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Renal Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Renal Disease Market Size by Product (2019-2025)
Figure Global Renal Disease Market Size by Product in 2025
Table Global Renal Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Renal Disease Market Size by Application (2019-2025)
Figure Global Renal Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---